FISH was performed in patients with a Her2/neu score of 2 by immunohistochemistry to confirm the diagnosis.Prostate, lung, skin, gastrointestinal system, and thyroid cancers can be seen as a secondary malignancy in 5-33% of male breast cancer patients (2,3,8,23). This evidence concerns the gene ERBB2 and breast cancer.